Recent News

July 30th Designated as National Whistleblower Appreciation Day

On July 16th, 2020,  the Senate unanimously passed a resolution designating July 30th, 2020 as National Whistleblower Appreciation Day for the eighth consecutive year. A whistleblower is an individual who, without authorization, reveals private or classified information about an organization, usually related to wrongdoing or misconduct. This date has historically been a meaningful date for…

Read More...

An Overview of Qui Tam and Why Whistleblowers Need Attorneys

In the Fiscal Year 2019 alone, individuals filed 633 qui tam lawsuits, an average of more than 12 cases a week, and the Department of Justice recovered over $3 billion from False Claims Act cases. Qui tam cases are lawsuits in which an individual reports fraud by an individual or corporation perpetrated against the federal…

Read More...

What to Do If You Are in an Automotive Accident

6 million car accidents occur every year, with three million people in the United States suffering from injuries as a result of car accidents. If you are involved in an automotive accident, especially one wherein you or a loved one is severely injured, the aftermath can be overwhelming in a variety of physical, mental and…

Read More...

Dr. Danielle Ofri Discusses Flaws in the Medical System That May Contribute to Medical Errors

In June 2020, Dr. Danielle Ofri, clinical professor of medicine at the New York University Medical School, discussed medical errors and flaws in the health care system that perpetuate them. In her book, When We Do Harm: A Doctor Confronts Medical Error, Ofri provides a thoughtful and honest analysis of patient safety and the medical…

Read More...

Elmiron Update: Warnings Changed to Include Risk of Eye Damage

On June 16th, 2020,  the Food and Drug Administration (FDA) announced labeling changes to Elmiron, a popular anticoagulant that is commonly prescribed to treat bladder pain caused by interstitial cystitis and osteoarthritis. Here, the pharmaceutical liability attorneys at Peter Angelos P.C. discuss the potential dangers to consumers taking Elmiron, and how to seek legal representation…

Read More...

Elmiron Linked to Vision Loss

Elmiron is a popular anticoagulant that is commonly prescribed to treat bladder pain caused by interstitial cystitis and osteoarthritis. Recently, Elmiron has been linked to the increased risk of pigmentary maculopathy and other forms of vision loss and damage. The pharmaceutical liability attorneys at Peter Angelos P.C. Law are actively investigating cases regarding the use…

Read More...

COVID-19 Business Interruption Coverage Denial Investigation

The global impacts of the COVID-19 pandemic continue to result in economic losses to businesses and individuals around the world. Additionally, governments are mandating that individuals quarantine themselves to contain the spread of the outbreak. These actions have resulted in changes in consumer behavior, and in turn, negatively impact many businesses. Here, the attorneys at…

Read More...

Continuous Surgical Staple Recalls Lead to Increased Litigation

For many years, defective surgical staples have caused irreparable harm to patients, but these dangers remained hidden. In 2019, the Food and Drug Administration (FDA) acknowledged that thousands of surgical staple malfunction reports were hidden from the public. Here, the medical device litigation team at Peter Angelos, P.C. discusses the various companies under scrutiny for…

Read More...

FDA Requests Removal of Zantac From the Market Immediately

On April 1st, the Food and Drug Administration (FDA) announced its request for all prescription and over-the-counter ranitidine drugs to be removed from the market immediately. This decision was made based on an ongoing investigation of possible carcinogenic effects of the contaminant N-nitrosodimethylamine, or NDMA. Here, the pharmaceutical liability attorneys at Peter Angelos, P.C. discuss…

Read More...

Singulair – FDA Strengthens Warning of Serious Mood and Behavorial Side Effects, Including Suicidal Thoughts, Associated with Common Allergy Medications

After convening a panel of outside experts, the FDA determined that the asthma and allergy medication montelukast, available as brand-name Singulair or in generic form, should include a Boxed Warning to ensure that health care professionals and patients are aware of the potential for severe mood-related side effects, particularly in children. Singulair, Along with Generic…

Read More...